BioHarvest Sciences Statistics
Total Valuation
BHST has a market cap or net worth of $34.00 million. The enterprise value is $33.47 million.
| Market Cap | 34.00M |
| Enterprise Value | 33.47M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BHST has 22.67 million shares outstanding. The number of shares has increased by 21.61% in one year.
| Current Share Class | 22.67M |
| Shares Outstanding | 22.67M |
| Shares Change (YoY) | +21.61% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 14.43% |
| Owned by Institutions (%) | 7.47% |
| Float | 19.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.93 |
| Forward PS | 0.80 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 1.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.79.
| Current Ratio | 2.24 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.12 |
Financial Efficiency
Return on equity (ROE) is -142.50% and return on invested capital (ROIC) is -15.25%.
| Return on Equity (ROE) | -142.50% |
| Return on Assets (ROA) | -11.02% |
| Return on Invested Capital (ROIC) | -15.25% |
| Return on Capital Employed (ROCE) | -19.40% |
| Weighted Average Cost of Capital (WACC) | 11.24% |
| Revenue Per Employee | $398,618 |
| Profits Per Employee | -$124,416 |
| Employee Count | 89 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, BHST has paid $97,000 in taxes.
| Income Tax | 97,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.69% in the last 52 weeks. The beta is 1.35, so BHST's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -86.69% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 3.68 |
| Relative Strength Index (RSI) | 23.89 |
| Average Volume (20 Days) | 33,050 |
Short Selling Information
The latest short interest is 95,360, so 0.42% of the outstanding shares have been sold short.
| Short Interest | 95,360 |
| Short Previous Month | 73,936 |
| Short % of Shares Out | 0.42% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 2.38 |
Income Statement
In the last 12 months, BHST had revenue of $35.48 million and -$11.07 million in losses. Loss per share was -$0.53.
| Revenue | 35.48M |
| Gross Profit | 20.91M |
| Operating Income | -6.38M |
| Pretax Income | -10.98M |
| Net Income | -11.07M |
| EBITDA | -5.80M |
| EBIT | -6.38M |
| Loss Per Share | -$0.53 |
Balance Sheet
The company has $16.22 million in cash and $15.70 million in debt, with a net cash position of $528,000 or $0.02 per share.
| Cash & Cash Equivalents | 16.22M |
| Total Debt | 15.70M |
| Net Cash | 528,000 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 19.76M |
| Book Value Per Share | 0.87 |
| Working Capital | 14.50M |
Cash Flow
In the last 12 months, operating cash flow was -$8.51 million and capital expenditures -$2.24 million, giving a free cash flow of -$10.75 million.
| Operating Cash Flow | -8.51M |
| Capital Expenditures | -2.24M |
| Depreciation & Amortization | 578,000 |
| Net Borrowing | -1.51M |
| Free Cash Flow | -10.75M |
| FCF Per Share | -$0.47 |
Margins
Gross margin is 58.95%, with operating and profit margins of -17.99% and -31.21%.
| Gross Margin | 58.95% |
| Operating Margin | -17.99% |
| Pretax Margin | -30.94% |
| Profit Margin | -31.21% |
| EBITDA Margin | -16.36% |
| EBIT Margin | -17.99% |
| FCF Margin | n/a |
Dividends & Yields
BHST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.61% |
| Shareholder Yield | -21.61% |
| Earnings Yield | -33.69% |
| FCF Yield | -32.72% |
Analyst Forecast
The average price target for BHST is $10.50, which is 600.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.50 |
| Price Target Difference | 600.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 25.82% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Jun 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
BHST has an Altman Z-Score of 0.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 3 |